Skip to main content

HOPA Abstracts

Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate vs Tacrolimus and Methotrexate as GVHD Prevention Following Allogeneic Stem Cell Transplant With Myeloablative Conditioning
Abstract #LB03
Read More
Real-World Clinical Outcomes With Fostamatinib for the Treatment of Refractory Chronic Immune Thrombocytopenia
Abstract #LB04
Read More
Unlocking Geographic Disparities in Lung Cancer Incidence Calls for Tailored Interventions and Pharmacist Partnerships
Abstract #LB05
Read More
Clinical Pharmacist–Initiated Tyrosine Kinase Inhibitor Discontinuation in Patients with Chronic Myeloid Leukemia
Abstract #CR05
Read More
Evaluation of Chemotherapy-Induced Myelosuppression in Patients with Extensive-Stage Small-Cell Lung Cancer Who Received Trilaciclib: Retrospective Analysis of Florida Community Oncology Practices
Abstract #CR06
Read More
Evaluation of the Safety of the New Alcohol-Containing Formulation of Cyclophosphamide
Abstract #CR07
Read More
Health System Specialty Pharmacy Integration Impact on Prescription Fill Time
Abstract #CR08
Read More
Invasive Fungal Disease in Patients with Hematologic Malignancies Receiving Micafungin Prophylaxis
Abstract #CR09
Read More
Knowledge Gaps and Educational Needs for Common Cancer Therapy–Related Cardiovascular Adverse Events and Related Drug Interactions
Abstract #CR10
Read More
Multidisciplinary Approach in Maximizing Oncology Clinic Throughput in a Comprehensive Cancer Center
Abstract #CR11
Read More
Page 6 of 12
Results 51 - 60 of 119